… The curative effect was evaluated as partial relief during chemotherapy according to … ,
controlled blood pressure, and no severe cardiovascular events within 6-12 mo. Furthermore, …

… Cardiovascular events related to new therapeutics have to be … be responsible for cholesterol
emboli syndrome in patients … enzyme inhibitors for bevacizumab-induced hypertension. …

… Radiation therapy can also lead to coronary artery disease and fibrotic … effect on the
renin-angiotensin system [27], and also may be responsible for cholesterol emboli syndrome [28]. …

… of the effects of chemotherapeutic agents on vascular toxicity … vascular damages that evoke
cardiovascular diseases and … risk of cholesterol embolization syndrome, leading to acute …

… stage renal disease (ESRD) and cardiovascular diseases 1 . … the incidences of
bevacizumab-induced nephrotic range and … artery stenosis with a cholesterol and …

… Gastrointestinal fistulas and perforations are recognized side effects of anti-angiogenic
therapies, however, there are very few reported cases of these conditions in patients managed …

… tions, such as embolization of the arteries, are controversial due to its adverse effects which
… Abnormal cortisol metabolism has been attributed to impaired processing of cholesterol …

… effects using the National Cancer Institute Common Terminology Criteria for Adverse Events,
which do not follow contemporary CV disease … of incidence of CV events and professional …

… Furthermore, low-density lipoprotein cholesterol may deposit … are at higher risk for fatal
cardiovascular events [62]. There … major acute cardiovascular events by having direct effects on …

… endocrine disease as the cause of their patient’s hypertension can greatly improve outcome.
… ’s initial presentation can include cardiovascular disease (CVD) or renal disease [3]. …